Seminar 20 Oct – Malaria Prevention: Progress and Prospects

BRCCH Seminar 20 Oct - Malaria Prevention: Progress and Prospects

 

Visual: Swiss TPH, fairpicture

 

Description:  The BRCCH cordially invites you to join our seminar addressing the progress and prospects of malaria prevention. Prof Simon Draper (University of Oxford, UK) will highlight the challenges, successes and future developments of vaccine-based solutions. Then, Prof Melissa Penny (Swiss TPH) will share her work on data analytics and modelling as product development support. Finally, Prof Evelyn Korkor Ansah (University of Health and Allied Sciences, Ghana) will provide insights into vaccine implementation and equitable distribution.

When: Thursday, October 20th, 2022 from 15:00-16:30 CET

Where: Hybrid Zoom / Kollengienhaus, Hörsaal 116, Petersgraben 50, 4051 Basel

Zoom Registration: HERE

In-person Registration (encouraged but not mandatory): HERE

Schedule:

      • Welcome by Prof Marcel Tanner (Swiss Academy of Arts and Sciences and Swiss TPH)
      • Prof Simon Draper (University of Oxford, UK): Malaria Vaccines – Recent Advances and Future Challenges (20 min)
      • Prof Melissa Penny (Swiss TPH): Data Analytics and Modelling Supporting Novel Malaria Prevention (20 min)
      • Prof Evelyn Korkor Ansah (University of Health and Allied Sciences, Ghana): Lessons from Malaria Vaccine Implementation in Ghana (20 min)
      • Q&A and Closing
      • Networking Apéro

Keynote speakers:

Prof Simon Draper

University of Oxford, UK

Simon Draper is a Professor of Vaccinology and Translational Medicine. The research undertaken in the Draper group focuses on the development of novel and improved approaches to blood-stage malaria vaccine design, as well as aiming to better understand molecular mechanisms of vaccine-induced immunity to blood-stage malaria infection. In particular, the group’s research interests span: strategies for improved vaccine antigen identification; development of improved vaccine delivery strategies; assessment of quantitative antibody correlates of protective immunity, and assessment of human vaccine-induced antibody responses to guide structure-based immunogen design and to better understand protective mechanisms of immunity.

A critical strength of the group is a strong dual focus on preclinical vaccine development in parallel with early-phase clinical vaccine testing and experimental medicine studies. There is a strong translational emphasis, with the most promising new approaches and/or candidate vaccines feeding into the Blood-Stage Malaria Clinical Trials Programme.

Prof Melissa Penny

Swiss Tropical and Public Health Institute & University of Basel, Switzerland

Melissa Penny is a professor and Head of the Disease Modelling research unit at Swiss TPH. She has more than 16 years of experience developing mathematical and computational models to provide quantitative evidence to support infectious disease control and elimination decisions, particularly for product development and policy decisions on new interventions.

She leads and has led international multi-institute consortia to provide evidence to WHO and other stakeholders for decision-making on new malaria interventions. This evidence includes the likely public health impact and cost-effectiveness of new interventions, such as the world’s first malaria vaccine RTS,S/AS01 (2015 and 2021), and, more recently, novel immune therapies. Her recent research focuses on developing data- and epidemiology-informed mathematical models and associated algorithms to understand pathogen, host, and intervention dynamics and to inform decisions during product development through implementation and policy recommendations. This work includes new approaches using mechanistic models to inform quantitative target product profiles for novel malaria tools. Her group has also developed new models of SARS-CoV-2 dynamics and applied them to inform decisions on novel interventions against COVID-19. She is also a member of several WHO scientific or technical working groups and WHO Guideline Development Groups.

She also leading a BRCCH-funded project to inform novel medical interventions against SARS-Cov-2 (find out more here).

 

Prof Evelyn Korkor Ansah

University of Health and Allied Sciences, Ghana

Evelyn Korkor Ansah is the Director of the Centre for Malaria Research. She is a Public Health Physician, an Epidemiologist, a fellow of the Ghana College of Physicians and Surgeons and a Rockefeller Foundation Bellagio Fellow. Prof Ansah was the Vice Chair of the Global Fund’s Technical Review Panel (TRP) to combat HIV/AIDS, Tuberculosis and Malaria until 2019. She currently serves on the WHO’s Malaria Policy Advisory Committee (MPAC) and Malaria Elimination Oversight Committee (MEOC). In addition to this, she serves on the Independent Evaluation Panel (IEP) of the Global Fund to fight HIV/AIDS and Malaria. Prior to this, she served on the Technical Evaluation Reference Group (TERG) of the Global Fund, the Bellagio Academic Selection Panel of the Rockefeller Foundation, and the Steering Committee of the ACT Consortium (involving over 15 institutions in several countries).

Her key research interests are malaria case management, diagnostics, health systems, maternal health and capacity building for health research. To this end, she has conducted a number of multi-country and local studies including clinical trials and health systems research.

BRCCH Seminar 6 July: Refining Paediatric Treatments for All

BRCCH Seminar 6 July: Refining Paediatric Treatments for All

**Update July 19th, 2022** Thank you to everyone that attended our hybrid seminar! We had a great turnout-- in case you missed the presentations or you would like to watch them again, you can now stream them below or on our YouTube channel.

Visual: Kiran Kuruvithadam

 

Description:  The BRCCH cordially invites you to join our seminar looking at Refining Paediatric Treatments for All. This event will highlight the research progress of Prof Thomas Erb (UKBB) on how to reduce the risk associated with the use of mechanical ventilation in children, and the efforts to improve competence in paediatric anaesthesia in Switzerland. Then, Dr Marianne Schmid Daners (ETH Zurich) will provide an overview of the challenges of paediatric hydrocephalus treatment. Finally, Prof Kokila Lakhoo (University of Oxford) will present her work in low- and middle-income countries on providing surgical treatments to children in need.

When: Wednesday, July 6th, 2022 from 16:00-17:30 CET

Where: Hybrid Zoom / UKBB seminar room, Spitalstrasse 33, 4056 Basel

Zoom Registration: HERE

In-person Registration (encouraged but not mandatory): HERE

Schedule:

      • Welcome by BRCCH Director Prof Georg Holländer
      • Prof Thomas Erb & his team (UKBB): "Safety first in children undergoing anaesthesia and sedation!" (25 min)
      • Dr Marianne Schmid Daners (ETH Zurich): "Challenges of paediatric hydrocephalus" (20 min)
      • Prof Kokila Lakhoo (University of Oxford): "Addressing the global health challenges for children with surgical needs in low- and middle-income countries" (40min, online)
      • Closing

Seminar Archive

Prof Thomas Erb (UKBB) presents "Safety first in children undergoing anaesthesia and sedation!" originally given on July 6th, 2022.

Dr Marianne Schmid Daners (ETH Zurich) presents"Challenges of Paediatric Hydrocephalus"originally given on July 6th, 2022.

Prof Kokila Lakhoo (University of Oxford) presents "Addressing the Global Health Challenges for Children with Surgical Needs in Low- and Middle-income Countries" originally given on July 6th, 2022.

Keynote Speakers:

Prof Kokila Lakhoo

Nuffield Department of Surgical Sciences, University of Oxford

Prof Kokila Lakhoo is a consultant paediatric surgeon at the Children’s Hospital in Oxford and the University of Oxford. She is also Chair of the International Forum for the British Association of Paediatric Surgeons and the President of the Global Initiative for Children’s Surgery (GICS). She is developing paediatric surgery through a link in Tanzania and has collaborative research projects in Malawi and South Africa. Besides general paediatric surgery and ambulatory surgery, her special interests are global health, fetal counselling, neonatal surgery, paediatric tumour surgery, paediatric thoracic surgery and specialist gastrointestinal surgery.

 

Prof Thomas Erb

University Children's Hospital Basel

Prof Thomas Erb completed his medical training with board examinations in anaesthesiology and critical care. Subsequently, he moved to Durham, North Carolina, USA, where he worked in the Pediatric Cardiology Program at Duke University. There, he also obtained a master of health sciences in clinical research. Returning to Switzerland in 2000, Prof Erb started his clinical research programme in the Department of Anaesthesiology at the University of Basel and University Children’s Hospital Basel (UKBB). In 2010, he became Titular Professor of Anaesthesiology, and in 2011 he was made Head of the Division of Paediatric Anaesthesia at UKBB. His clinical interests and research are focused on the effects of anaesthetic conditions on airway and lung mechanics in children. He is currently leading the BRCCH-funded COVent project aiming to develop practical solutions that reduce the risks associated with the use of mechanical ventilation, especially those associated with low-cost/do-it-yourself ventilators and off-label use that are now available in many resource-limited settings.

 

 

Dr Marianne Schmid Daners

Institute of Design, Materials and Fabrication, ETH Zurich

Dr Marianne Schmid Daners graduated from ETH Zurich as a mechanical engineer. She then completed her doctorate on the topic of “Adaptive Shunts for Cerebrospinal Fluid Control” at ETH Zurich’s Institute for Dynamic Systems and Control. Dr Schmid Daners heads the institute’s Biomedical Systems Group as a senior scientist. At the interdisciplinary interface of clinical research and engineering, her passion is the pathophysiological understanding of the dynamics of the intracranial and cardiovascular systems. Her research focuses on the modelling, control and testing of biological systems, as well as on the development and control of biomedical devices for the treatment of heart failure and hydrocephalus.

Takeaways from Panel Discussion: Impact of COVID-19 on Global Paediatric Health

Takeaways from Panel Discussion: Impact of COVID-19 on Global Paediatric Health

On May 24th 2022, a panel of experts highlighted several important facets of the consequences that COVID-19 pandemic has on the global paediatric health situation:

- decreased access to vital child healthcare services like newborn care and immunisation
- increased poverty
- more nutritional and physical activity deprivation
- mental impairment
- compromised learning and loss of a caregiver

Moderator: Prof Julia Dratva, Zurich University of Applied Sciences (ZHAW) & University of Basel, Switzerland

Panel members: Prof Yvonne Maldonado, Stanford University, USA; Prof Alan Stein, University of Oxford, UK; Dr Marc Birkhölzer, University of Basel, Switzerland; Prof Thomas Berger, Secretary and Chief Medical Advisor at NEO FOR NAMIBIA

More about the event here.

Find out more about our speakers and read about their takeaways below

 

From left to right: Prof Julia Dratva, Dr Marc Birkhölzer, Prof Yvonne Maldonado, Prof Thomas Berger. (Prof Alan Stein joined remotely, not pictured)

 

 

Prof Yvonne Maldonado

Dr Marc Birkhölzer

Prof Alan Stein

Prof Thomas Berger

Prof Julia Dratva

Impact of COVID-19 on Global Paediatric Health – Panel Discussion

Impact of COVID-19 on Global Paediatric Health

Join us during an interactive debate with a panel of experts on the topic: How the COVID-19 Pandemic has affected Global Paediatric Health. The discussion will mainly focus on: i) mental health in young people, ii) disruption to life-saving paediatric health services such as immunisation and antenatal care.

Tuesday, May 24th 2022 (16.00-17.15 pm CET)

Moderator: Prof Julia Dratva, Zurich University of Applied Sciences (ZHAW) & University of Basel, Switzerland

Panel members: Prof Yvonne Maldonado, Stanford University, USA; Prof Alan Steiner, University of Oxford, UK; Dr Marc Birkhölzer, University of Basel, Switzerland; Prof Thomas Berger, Secretary and Chief Medical Advisor at NEO FOR NAMIBIA

Find out more about our speakers below

The event is taking place in a hybrid format:

The number of seats at Basel Biozentrum is limited, please register here.

Interested in joining virtually? Sign up here!

For more information, contact Dr Amandine Bovay, BRCCH Scientific Officer and Development Manager (amandine.bovay@brc.ch)

*Update 1 June 2022: In case you missed the event, you can read the discussion takeaways here.

Programme Speakers:

Prof Yvonne Maldonado
Division of Infectious Diseases, Department of Pediatrics
Department of Epidemiology and Population Health                                 Stanford University School of Medicine, USA

Yvonne Maldonado is Professor of paediatrics, epidemiology, and population health, and Chief of the division of paediatric infectious diseases at the School of Medicine, Stanford University. She also currently serves as Stanford Medicine’s Senior Associate Dean of Faculty Development and Diversity. Prof Maldonado's research focuses on the epidemiology and prevention of viral infectious diseases such as paediatric HIV, polio, measles and Ebola. Her work on mother-to-child transmission of HIV in sub-Saharan Africa is credited for preventing hundreds of thousands of newborns from acquiring HIV. She also leads research on the development and implementation of vaccines in low- and middle-income countries.

Visual: Stanford University

Prof Julia Dratva
Institute of Public Health, ZHAW Zurich University of Applied Sciences, Switzerland
Medical Faculty, University of Basel, Switzerland

Prof Julia Dratva is a public health expert with a focus on child and adolescent health and early life factors of health and disease. She is the Head of the Public Health Research Unit at the Zurich University of Applied Sciences (ZHAW) and an Assistant Professor in the Medical Faculty at the University of Basel.

Prof Dratva is a medical doctor by training with a background in internal medicine. She also holds a Master degree in Public Health and a Specialist Certification (FMH) for "Prevention and Public Health". She has a particular interest in the life course approach to health and disease in research and teaching, addressing vulnerable groups and vulnerable time spans. She also has research interests in cardiovascular health, health monitoring, health literacy and digital health.

Prof Alan Stein
Department of Psychiatry, University of Oxford, UK

Alan Stein is Professor of Child & Adolescent Psychiatry at the University of Oxford, Honorary Professor in the School of Public health at the University of Witwatersrand and a member of the faculty of the African Health Research Institute, South Africa. His main area of research concerns the development of children and adolescents in the face of adversity. Ultimately the priority is to develop interventions. He has led three Lancet series on: i) The mental health of internally displaced and refugee children, ii) Perinatal mental health, iii) The communication of life-threatening conditions to children.

Prof Thomas Berger
Secretary and Chief Medical Advisor at NEO FOR NAMIBIA - Helping Babies Survive

Prof Thomas Berger is a paediatrician specialised in neonatology and intensive care. With more than 25 years of experience in neonatology in various high-income countries, he decided to share his knowledge with physicians and nurses in less privileged countries. Therefore, he and his wife founded the non-profit organisation NEO FOR NAMIBIA – Helping Babies Survive in 2017. The team has just launched their 14th mission in Rundu State Hospital to improve neonatal and paediatric care in Namibia.

Dr Marc Birkhölzer
Psychiatrist, University of Basel, Swizterland

Dr Marc Birkhölzer is currently a senior physician at the Juvenile Forensic Department of the Psychiatric University Clinics of Basel (UPK). His research focuses on personality disorders. Over the years, he has built an extraordinary network of collaborators in countries all over the world.

BRCCH Early-Career Programme

BRCCH's Early-Career Events 2021-2022

The BRCCH endeavours to foster the development of aspiring young researchers who will pioneer the next frontiers in global paediatric medicine and health. The BRCCH’s Early Career Programme aims to provide unique opportunities for its community members to gain know-how in research areas at the heart of the Centre’s mission and to grow their global network.

This upcoming year (late 2021-mid 2022), the BRCCH invites its early-career community members to join local and international speakers in a series of interactive workshops on topics across the Centre’s mandate.

For more information and registration, contact Dr. Amandine Bovay, BRCCH Scientific Officer and Development Manager (amandine.bovay@brc.ch)

Webinar: Community-based COVID-19 Testing in Lesotho and Zambia

Webinar: Community-based COVID-19 Testing in Lesotho and Zambia

Visual: SolidarMed & Swiss TPH

 

Description:  The BRCCH cordially invites you to join us online for a webinar looking at Community-based COVID-19 testing in Lesotho and Zambia. This event will highlight research progress of the collaborative project between Dr Kwame Shanaube (Zambart) and Dr Klaus Reither (Swiss TPH) on the effects of community-led interventions in mitigating the COVID-19 epidemics in Lesotho and Zambia. The BRCCH and the European & Developing Countries Clinical Trials Partnership (EDCTP) partnered on a joint initiative to support multi-national collaborations for research to mitigate COVID-19, particularly in low- and middle-income countries.

When: Wednesday, April 27th, 2022 from 15:30-17:00 CET

Where: Online, Zoom seminar

Registration: HERE

Schedule:

      • Welcome by BRCCH Director Prof Georg Holländer
      • Keynote lecture by Dr Kwame Shanaube (Zambart), Dr Klaus Reither (Swiss TPH) & their research teams:
              1. Overview of the joint BRCCH-EDCTP project: Improving Access to SARS-CoV-2 Screening and Testing through Community-based COVID-19 Case-Finding and the Use of Digital Solutions in Lesotho and Zambia
              2. Comparing different approaches of community-based SARS-CoV-2 testing in Lesotho and Zambia
              3. Barriers and facilitators to SARS-CoV-2 testing at community-based testing sites
              4. Evaluation of SARS-CoV-2 tests and testing approaches
      • Plenary discussion
      • Closing

Keynote Speakers:

 

 

Dr Kwame Shanaube

Zambart & School of Public Health, University of Zambia

Dr Kwame Shanaube is Deputy Director of Research (Quantitative) at Zambart, a multidisciplinary research organisation that conducts a range of studies including clinical trials, epidemiological studies and laboratory-based diagnostic studies. She is a clinician with a Master’s degree in public health and a PhD in TB clinical epidemiology. She is also an honorary lecturer at the University of Zambia School of Public Health. Her research interests cover a wide range of disciplines, including TB/HIV epidemiology, community-based cluster randomised trials, operational research through evaluation of field diagnostics and adolescent health. She is also the country’s Principal Investigator for a large international TB consortium (the TREATS Project) and the overall Principal Investigator for the TREATS-COVID study, both funded by the EDCTP.

 

Dr Klaus Reither

Clinical Research Unit, Swiss Tropical and Public Health Institute

Dr Klaus Reither is Head of the Clinical Research Unit and the leader of the Clinical TB Research Group at the Swiss Tropical and Public Health Institute (Swiss TPH). He oversees and coordinates clinical research projects conducted by Swiss TPH and his research responsibilities comprise the set-up, implementation, coordination and supervision of clinical research projects, with an emphasis on TB clinical trials at Swiss TPH’s international partner organisations such as the Ifakara Health Institute in Tanzania, the National Centre of Tuberculosis and Lung Diseases in Georgia and SolidarMed in Lesotho.

Dr Reither is Lead Investigator of the BRCCH COVID-19 project: MistraL - Mitigation Strategies for Communities with COVID-19 Transmission in Lesotho Using Artificial Intelligence on Chest X-rays and Novel Rapid Diagnostic Tests. Together with Dr Kwame Shanaube, he also co-leads a BRCCH-EDCTP collaborative project on Improving Access to SARS-CoV-2 Screening and Testing through Community-based COVID-19 Case-Finding and the Use of Digital Solutions in Lesotho and Zambia.

 

Webinar: Future of COVID-19 Research

Webinar: Future of COVID-19 Research

**Update October 28th, 2021 ** Thank you to everyone that attended our webinar! We had a great turnout-- in case you missed the presentations or you would like to watch them again, you can now stream them below or on our YouTube channel.

visual: background image courtesy of National Institute of Allergy and Infectious Diseases

 

Description: The BRCCH cordially invites you to join us online for a webinar looking at The Future of COVID-19 Research. This event will highlight significant research progress and the roadmap ahead related to immunology, epidemiology and bioengineering. Gain insights from our keynote speakers and engage with them during the Q&A panel discussion.

When: Thursday, October 21st, 2021 from 15:00-17:00 CET

Where: online, livestream Zoom seminar

Schedule:
Welcome by BRCCH Vice Director Prof Sai Reddy
Keynote lecture by Prof Teresa Lambe OBE (University of Oxford)
     "Development and testing of the Oxford/AstraZeneca vaccine"
Keynote lecture by Prof Benjamin Murrell (Karolinska Institutet)
     "Neutralizing SARS-CoV-2 variants"
Keynote lecture by Prof Sai Reddy (ETH Zurich and BRCCH)
     "Identifying prospective variants of SARS-CoV-2 by deep mutational learning"
Q&A Panel Discussion
Closing

Webinar Archive

Prof Teresa Lambe OBE (University of Oxford) presents "Development and Testing of the ChAdOx1 nCoV-19/AZD1222 Vaccine" originally webcast on October 21st, 2021.

 

Prof Benjamin Murrell (Karolinska Institutet) presents "Neutralizing SARS-CoV-2 Variants" originally webcast on October 21st, 2021.

 

Prof Sai Reddy (ETH Zurich and BRCCH) presents "Identifying Prospective Variants of SARS-CoV-2 by Deep Mutational Learning" originally webcast on October 21st, 2021.

Keynote Speakers:

Prof Teresa Lambe OBE
The Lambe Group for Emerging Pathogens
The Oxford Vaccine Group and the Jenner Institute Laboratories
Dept of Paediatrics, University of Oxford

Assoc Prof Lambe will share her research insights into the immune response to SARS-CoV-2 and its vaccine. Her research group is part of the Covid-19 vaccine trial in the UK and has co-designed the vaccine and led the development and testing of the immune response after vaccination.

Prof Lambe’s research investigates the establishment of protective immune responses following vaccination and the formation of adaptive immune memory. She is particularly interested in delineating the immune response post vaccination and also post natural infection to help develop vaccines and define correlates of protection. At the University of Oxford, her group uses platform technologies to develop vaccines against emerging and re-emerging pathogens. The group is currently developing vaccines against a number of outbreak pathogens including Crimean-Congo haemorrhagic fever virus, Lassa virus, Nipah virus, Influenza, Ebolavirus and coronaviruses.

Visual: John Cairns/University of Oxford

Prof Benjamin Murrell
Department of Microbiology, Tumor and Cell Biology
Karolinska Institutet

Prof Murrell will speak about his work on the H2020 CoroNAb project, studying antibodies and isolating nanobodies against SARS-CoV-2.

Prof Murrell's previous research interests surrounded the evolution of the HIV envelope protein, and antibodies against it. Recently, he has applied this expertise to SARS-CoV-2 and its variants. Together with colleagues, he has identified nanobodies from immunized alpacas that may be potential SARS-CoV-2 therapeutics, and has conducted preclinical immunization studies attempting to boost responses to SARS-CoV-2 variants. This work is part of the CoroNAb consortium research project, funded under Horizon2020 as part of the EU’s emergency funding call for COVID-19.

Visual: Karolinska Institutet

Prof Sai Reddy
Laboratory for Systems and Synthetic Immunology
Department of Biosystems Science and Engineering, ETH Zurich
And Vice Director BRCCH

Prof Reddy shares his recent work on developing a simultaneous diagnostic and genomic surveillance method for SARS-CoV-2 based on targeted deep sequencing. He will also present new data from his group related to identifying variants of SARS-CoV-2 using a novel method called deep mutational learning. 

Prof Reddy’s research is focused on the emerging field of systems and synthetic immunology, with an aim towards developing technologies relevant to immunotherapy and biotechnology. He has developed a number of methods in systems immunology to improve our understanding of adaptive immunity, with a particular focus on immune repertoire sequencing. Recently, he founded two spin-off companies, deepCDR Biologics and Engimmune Therapeutics, which are both based on technologies developed in his research group on engineering antibodies or T cells.

Webinar: Insights Into COVID-19 Research

Webinar: Insights Into
COVID-19 Research

The BRCCH invites you to join us online for free webinars on COVID-19.

**Update September 17th, 2020 ** Thank you to everyone that attended our webinars in September! We had a great turnout-- in case you missed the presentations or you would like to watch them again, you can now stream them below or on our YouTube channel

    Description: The pandemic is placing the world in a stress test that is unprecedented. In response, organizations across sectors from research to nonprofit are mobilizing resources and taking action. This 3-part webinar series will highlight the BRCCH's ongoing collaborative research efforts in Switzerland, as well as dip into the global conversation about the current challenges and latest developments in the race to respond to the pandemic, with a focus on low- and middle-income countries.

    Sept 2nd & 9th: We will take an in-depth look into recently launched research projects focused on diagnostics and the immunology of COVID-19, as well as others focused on novel medical interventions for COVID-19. The projects are part of our recent Fast Track Initiative for COVID-19.

    Sept 16th: During the panel discussion, we will hear first hand from international experts about the current landscape of public health and how technology and partnerships spanning borders could meet current challenges in the pandemic.

    Register: closed. In case you missed the webinars, you can now watch them here (scroll down) or on our Youtube channel
    More: Download our programme below for info on the talks and speakers

    Banner image: Produced by the National Institute of Allergy and Infectious Diseases (NIAID), this highly magnified, digitally colorized transmission electron microscopic (TEM) image reveals ultrastructural details exhibited by three, spherical shaped, Middle East respiratory syndrome coronavirus (MERS-CoV) virions.

    Webinar Archive

    Prof Janos Vörös (ETH Zurich) & PD Dr Michael Osthoff (University Hospital Basel) present "A mobile, rapid diagnostic test system for COVID-19 based on lateral flow assays diagnosing SARS-CoV-2 infections at point-of-need," originally webcast on Sep 2nd, 2020.

     

    Prof Andreas Moor (ETH Zurich) presents "B cell immunity in convalescent COVID-19 patients with the aim of identifying high-affinity antibodies against SARS-CoV-2" originally webcast on Sep 2nd, 2020.

     

    Prof Melissa Penny (Swiss TPH) & Prof Roland Regoes (ETH Zurich) present "Modelling and machine learning to optimise medical interventions and health strategies for emergency response to the pandemic" originally webcast on Sep 9th, 2020.

     

    Prof Thomas Erb (University Children's Hospital Basel) & Prof Mirko Meboldt (ETH Zurich) present "The challenge of ventilation in the COVID-19 pandemic - improved patient care with low-cost ventilators based on novel integrated pressure sensors" originally webcast on Sep 9th, 2020.

     

    International Panel Discussion
    Prof Alain Labrique (Global mHealth Initiative, Johns Hopkins University) &
    Dr Solomzi Makohliso (EssentialTech, EPFL) &
    Prof Marcel Tanner (Swiss Academy of Sciences | Fondation Botnar)  &
    Akhona Tshangela (Africa Centres for Disease Control and Prevention) &
    Moderated by Dr Maxine Mackintosh (One HealthTech | The Alan Turing Institute)

    Inaugural BRCCH Spotlight Day

    The inaugural Spotlight Day of the BRCCH marked the start of our initiative to build a community, both locally and globally, around the central mission of improving the health and well-being of children and adolescents worldwide. This event was an opportunity for local and international community to meet, start new dialogues and enable fruitful collaborations.

    More than 200 visitors joined the BRCCH at the inaugural Spotlight Day on January 30, 2020 – a great turnout to the Centre's first public event. After inspiring welcome addresses by Andrea Schenker-Wicki and Detlef Günther, four new BRCCH Multi-Investigator Projects showcased their vision for the next 5 years. Three international keynote speakers gave new perspectives on how research can be applied and translated. With this event, the BRCCH welcomed our new research projects at the Centre and the start of their research activities at the BRCCH.

    Watch a summary of the event:

     

    Artist Alex Hughes (Drawnalism) illustrated the event:

       

      The event programme: